Cardiac Dimensions nabs $15.2 mln

Cardiac Dimensions, a developer of minimally invasive treatments that address heart failure and related cardiovascular conditions, has raised $15.2 million in funding. The investors included Life Sciences Partners, Aperture Venture Partners, Lumira Capital, M.H. Carnegie & Co. and Arboretum Ventures.

Vascular Pharmaceuticals snares $9 mln

Research Triangle Park, North Carolina-based Vascular Pharmaceuticals Inc, a diabetes-focused pharmaceutical company, has secured $9 million in Series A funding. The investors included Lumira Capital, Intersouth Partners and MPM Capital. In addition to the funding, Dr. Beni Rovinski, managing director of Lumira Capital, has been added to VPI’s board of directors.

DC Devices picks up $34 mln Series D

DC Devices, a medical device firm focused on treating heart failure, has secured $34 million in Series D funding. Accelmed led the round with participation from investors that included Third Rock Ventures, General Catalyst Partners and Lumira Capital.

Cardiac Dimensions picks up $20 mln

Cardiac Dimensions said Wednesday that it has raised $20 million in funding. M. H. Carnegie & Co. and Lumira Capital led the round. Cardiac Dimensions is a developer of minimally invasive treatments that address heart failure and related cardiovascular conditions.

BAROnova Closes Series C

trong>BAROnova has closed its Series C financing of $27.3 million, led by investments from Sante Ventures and Boston Scientific Corporation, an innovator of medical devices and technologies. Investors included Series B investors ONSET Ventures, Highland Capital Partners and Arboretum Ventures, along with new investor Lumira Capital. Financial terms were not disclosed.

Ontario Venture Capital Fund Commits $70 million to Three Funds

Ontario Venture Capital Fund (OVCF) has committed $70 million to three Ontario-focused VC funds: Lumira Capital II, Celtic House Venture Partners IV and Rho Canada Ventures II. PRESS RELEASE: Ontario Venture Capital Fund (OVCF) today announced it has recently made commitments totalling $70 million to three leading Ontario-focused venture capital funds: Lumira Capital II, Celtic House […]

U-Systems Closes on $6.5M

U-Systems, a developer of automated breast ultrasound technology, has closed on $6.5 million from investors including iD SoftCapital Group, Lumira Capital, PIIH, Radius Ventures, and Sycamore Ventures. The company will use the funds to complete a clinical study, and complete submissions for regulatory approval with the Food and Drug Administration. U-Systems is based in Sunnyvale, Calif.

Lumira Capital Raising New Fund

Lumira Capital is planning to raise between $250 million and $300 million for its second fund, according to VentureWire. The Toronto-based VC firm was previously known as MDS Capital Corp., and focuses on the life sciences sector.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget